SDM for Stroke Prevention in Atrial Fibrillation

The goal of this study is to determine the extent to which the Anticoagulation Choice tool
promotes shared decision making and its impact on anticoagulation use and adherence versus
standard care in patients with nonvalvular atrial fibrillation.

Clinician Inclusion Criteria:

• All clinicians (MDs, NP/PAs, PharmDs) that are responsible for the modality of
Anticoagulation in eligible AF patients at participating sites, without exclusion

Patient Inclusion Criteria:

- ≥ 18 years of age

- Chronic nonvalvular atrial fibrillation deemed at high risk of thromboembolic strokes
(CHA2D2-VASc Score ≥ 1, or 2 in women)

- Able to read and understand (despite cognitive, sensorial, hearing or language
challenges) the informed consent document as determined by the study coordinator
during consent

Patient Exclusion Criteria:

• Clinician indicates that patient is not a candidate for a discussion about
anticoagulation medication